Literature DB >> 3496354

In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions.

D Safar, S Berrih-Aknin, E Morel.   

Abstract

In vitro anti-acetylcholine receptor antibody (anti-AChR Ab) production by peripheral blood lymphocytes (PBL) and thymic lymphocytes was investigated in 52 patients with myasthenia gravis (MG). There was a positive correlation between in vitro anti-AChR Ab synthesis and in vivo titers. A relationship between the rates of synthesis by PBL and histological abnormalities of the thymus was also observed. Patients with hyperplastic thymus tended to produce the largest amounts in vitro, while those with an involuted thymus produced little or none. Production in thymoma patients is likely to correlate with the histological nature of the thymus associated with the tumor. In vitro Ab synthesis was modulated by the depletion of a cell subset for half of the patients tested. Finally, anti-AChR Ab production by thymocytes but not by PBL is enhanced by the addition of autologous or allogeneic thymic epithelial cells, suggesting a possible role of thymic epithelial cells in the autosensitization against AChR occurring in the thymus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496354     DOI: 10.1007/BF00915728

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Letter: B lymphocytes in the thymus of patients with myasthenia gravis.

Authors:  F G Staber; U Fink; W Sack
Journal:  N Engl J Med       Date:  1975-05-08       Impact factor: 91.245

2.  Extracellular matrix of the human thymus: immunofluorescence studies on frozen sections and cultured epithelial cells.

Authors:  S Berrih; W Savino; S Cohen
Journal:  J Histochem Cytochem       Date:  1985-07       Impact factor: 2.479

Review 3.  The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases.

Authors:  S Berrih-Aknin; E Morel; F Raimond; D Safar; C Gaud; J P Binet; P Levasseur; J F Bach
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

4.  Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen.

Authors:  S M McLachlan; A M Dickinson; A Malcolm; J R Farndon; E Young; S J Proctor; B R Smith
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

5.  Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology.

Authors:  G K Scadding; A Vincent; J Newsom-Davis; K Henry
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

6.  Acetylcholine receptor antibody synthesis in lymphocyte cultures.

Authors:  S M McLachlan; L V Nicholson; G Venables; F L Mastalgia; D Bates; B R Smith; R Hall
Journal:  J Clin Lab Immunol       Date:  1981-05

7.  Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.

Authors:  J Newsom-Davis; N Willcox; L Calder
Journal:  N Engl J Med       Date:  1981-11-26       Impact factor: 91.245

8.  Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.

Authors:  B Vernet-der Garabedian; E Morel; J F Bach
Journal:  J Neuroimmunol       Date:  1986-07       Impact factor: 3.478

9.  Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.

Authors:  S Berrih; C Gaud; M A Bach; H Le Brigand; J P Binet; J F Bach
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

10.  Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population.

Authors:  Y Thomas; L Rogozinski; O H Irigoyen; S M Friedman; P C Kung; G Goldstein; L Chess
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  7 in total

1.  Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia.

Authors:  Rozen Le Panse; Géraldine Cizeron-Clairac; Jacky Bismuth; Sonia Berrih-Aknin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Phenotypic characteristics of thymic B lymphocytes in myasthenia gravis.

Authors:  B Zweiman; A I Levinson; R P Lisak
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

3.  Cellular aspects of myasthenia gravis.

Authors:  S Berrih-Aknin; S Cohen-Kaminsky; D Neumann; D Safar; B Eymard; C Gaud; P Levasseur; S Fuchs; J F Bach
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 4.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

5.  Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.

Authors:  Julia Miriam Weiss; Marieke Robinet; Revital Aricha; Perrine Cufi; Bérengère Villeret; Frida Lantner; Idit Shachar; Sara Fuchs; Miriam C Souroujon; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Oncotarget       Date:  2016-02-16

Review 6.  New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Authors:  Anthony Behin; Rozen Le Panse
Journal:  J Neuromuscul Dis       Date:  2018

Review 7.  Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology.

Authors:  Miriam L Fichtner; Ruoyi Jiang; Aoibh Bourke; Richard J Nowak; Kevin C O'Connor
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.